Please enter your username or email address. You will receive a link to create a new password via email.
© 2023 MergersCorp M&A International. is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://www.mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This company has been working on synthetic bone tissue and cartilage tissue scaffolds in the biomedical sector since 2017 as a technocity company. It continues its production and R&D activities with its 30 personnel with 520,000 cc capacity in 150-7 (Class 10000) at Ege University Technology Development Center and ISO-5 (Class 100), ISO-6 (Class 1000) and ISO-7 (Class 10000) clean room conditions in Manisa.
It is a biotech based company that focuses on the design, development, manufacture and marketing of innovative synthetic bone graft products. In addition to its high-tech production and quality control devices, it continues its R&D investment uninterruptedly, with the support of its expert employees and strong capital structure.
It is the largest of the three manufacturers in synthetic bone graft market of Turkey and is also biggest of the exporters. With its export-oriented growth strategy, it has completed its certification processes in 55 countries in 3 years and exports to these countries. The market it is addressing abroad is 3096 of the total market.
With the FDA approval, it will continue its growth studies in America and Asia-Pacific.
Spine surgery still works heavily and aims to grow rapidly in orthopedics and dental fields. As of 2021, it will increase its effectiveness in the market with 3 new products.
Gross Revenue
TBA
EBITDA
TBA
Business ID:
L#20210180
Country
Turkey
Business ID: | L#20210180 |
Property Type: | Manufacturing |
Property Status: | For Sale |
Target Price: | €8,000,000 |
Gross Revenue: | TBA |
EBITDA: | TBA |
Target Price / Revenue: | INFx |
Target Price / EBITDA: | INFx |
Published on October 19, 2021 at 9:34 am. Updated on October 19, 2021 at 9:39 am
€8,500,000
Manufacturing
This company has been working on synthetic bone tissue and cartilage tissue scaffolds in the biomedical sector since 2017 as a technocity company. It continues its production and R&D activities with its 30 personnel with 520,000 cc capacity in 150-7 (Class 10000) at Ege University Technology Development Center and ISO-5 (Class 100), ISO-6 (Class 1000) and ISO-7 (Class 10000) clean room conditions in Manisa.
It is a biotech based company that focuses on the design, development, manufacture and marketing of innovative synthetic bone graft products. In addition to its high-tech production and quality control devices, it continues its R&D investment uninterruptedly, with the support of its expert employees and strong capital structure.
It is the largest of the three manufacturers in synthetic bone graft market of Turkey and is also biggest of the exporters. With its export-oriented growth strategy, it has completed its certification processes in 55 countries in 3 years and exports to these countries. The market it is addressing abroad is 3096 of the total market.
With the FDA approval, it will continue its growth studies in America and Asia-Pacific.
Spine surgery still works heavily and aims to grow rapidly in orthopedics and dental fields. As of 2021, it will increase its effectiveness in the market with 3 new products.
© 2023 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://www.mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc a US Corporation with registered office at
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.
Error: Contact form not found.